These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22060010)

  • 1. Variation in local institutional review board evaluations of a multicenter patient safety study.
    Thompson DA; Kass N; Holzmueller C; Marsteller JA; Martinez EA; Gurses AP; Kanchuger M; Schwann N; Gibson CS; Bauer L; Pronovost PJ
    J Healthc Qual; 2012; 34(4):33-9. PubMed ID: 22060010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Institutional review board variability in minimal-risk multicenter urogynecology studies.
    Harvie HS; Lowenstein L; Omotosho TB; Sanses T; Molden S; Hardy J; Brubaker L;
    Female Pelvic Med Reconstr Surg; 2012; 18(2):89-92. PubMed ID: 22453318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review finds that multicenter studies face substantial challenges but strategies exist to achieve Institutional Review Board approval.
    Greene SM; Geiger AM
    J Clin Epidemiol; 2006 Aug; 59(8):784-90. PubMed ID: 16828670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of central institutional review boards for multicenter clinical trials in the United States: a review of the literature.
    Check DK; Weinfurt KP; Dombeck CB; Kramer JM; Flynn KE
    Clin Trials; 2013 Aug; 10(4):560-7. PubMed ID: 23666951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches to facilitate institutional review board approval of multicenter research studies.
    Marsolo K
    Med Care; 2012 Jul; 50 Suppl():S77-81. PubMed ID: 22692264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in institutional review board responses to a standard, observational, pediatric research protocol.
    Mansbach J; Acholonu U; Clark S; Camargo CA
    Acad Emerg Med; 2007 Apr; 14(4):377-80. PubMed ID: 17312334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practice-based research network studies and institutional review boards: two new issues.
    Yawn BP; Graham DG; Bertram SL; Kurland MJ; Dietrich AJ; Wollan PC; Brandt EC; Huff JM; Pace WD
    J Am Board Fam Med; 2009; 22(4):453-60. PubMed ID: 19587261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in standards of research compensation and child assent practices: a comparison of 69 institutional review board-approved informed permission and assent forms for 3 multicenter pediatric clinical trials.
    Kimberly MB; Hoehn KS; Feudtner C; Nelson RM; Schreiner M
    Pediatrics; 2006 May; 117(5):1706-11. PubMed ID: 16651328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of multicenter studies by multiple institutional review boards: characteristics and outcomes for perinatal studies implemented by a multicenter network.
    Abramovici A; Salazar A; Edvalson T; Gallagher N; Dorman K; Tita A;
    Am J Obstet Gynecol; 2015 Jan; 212(1):110.e1-6. PubMed ID: 25088862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Problematic variation in local institutional review of a multicenter genetic epidemiology study.
    McWilliams R; Hoover-Fong J; Hamosh A; Beck S; Beaty T; Cutting G
    JAMA; 2003 Jul; 290(3):360-6. PubMed ID: 12865377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Informed consent for research on stored blood and tissue samples: a survey of institutional review board practices.
    White MT; Gamm J
    Account Res; 2002; 9(1):1-16. PubMed ID: 12705242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of warning letters issued to institutional review boards by the United States Food and Drug Administration.
    Bramstedt KA; Kassimatis K
    Clin Invest Med; 2004 Dec; 27(6):316-23. PubMed ID: 15675112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical education research and IRB review: an analysis and comparison of the IRB review process at six institutions.
    Dyrbye LN; Thomas MR; Mechaber AJ; Eacker A; Harper W; Massie FS; Power DV; Shanafelt TD
    Acad Med; 2007 Jul; 82(7):654-60. PubMed ID: 17595560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Federal commissions and local IRBs.
    Yesley MS
    Hastings Cent Rep; 1983 Oct; 13(5):11-2. PubMed ID: 6643032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concept paper: a virtual centralized IRB system.
    McWilliams R; Hebden CW; Gilpin AM
    Account Res; 2006; 13(1):25-45. PubMed ID: 16770858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability of the institutional review board process within a national research network.
    Khan MA; Barratt MS; Krugman SD; Serwint JR; Dumont-Driscoll M;
    Clin Pediatr (Phila); 2014 Jun; 53(6):556-60. PubMed ID: 24658908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grinding to a halt: the effects of the increasing regulatory burden on research and quality improvement efforts.
    Infectious Diseases Society of America
    Clin Infect Dis; 2009 Aug; 49(3):328-35. PubMed ID: 19566438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability in IRBs regarding parental acceptance of passive consent.
    Higgerson RA; Olsho LE; Christie LM; Rehder K; Doksum T; Gedeit R; Giuliano JS; Brennan B; Wendlandt R; Randolph AG;
    Pediatrics; 2014 Aug; 134(2):e496-503. PubMed ID: 25002659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exception from informed consent: viewpoint of institutional review boards--balancing risks to subjects, community consultation, and future directions.
    Ernst AA; Fish S
    Acad Emerg Med; 2005 Nov; 12(11):1050-5. PubMed ID: 16264073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to do human-subjects research if you do not have an institutional review board.
    Rice TW
    Respir Care; 2008 Oct; 53(10):1362-7. PubMed ID: 18812001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.